D-268-2013 Class II Terminated

Recalled by Sandoz Incorporated — Broomfield, CO

FDA drug recall D-268-2013 was initiated by Sandoz Incorporated on April 18, 2013 and is designated Class II. Reason for recall: Presence of Foreign Substance, Sandoz is recalling certain lots of Amoxicillin Capsules, USP 500 mg due to potential contamination with fragments of stainless steel wire mesh. The recall status is terminated (terminated February 26, 2014). Affected quantity: 8286 x 30 ct, 37108 x 500 ct. bottles.

Recall Details

Product Type
Drugs
Report Date
May 1, 2013
Initiation Date
April 18, 2013
Termination Date
February 26, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8286 x 30 ct, 37108 x 500 ct. bottles

Product Description

Amoxicillin Capsules USP 500 mg, Manufactured in Austria by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540, Rx only. Manufactured in 500 ct (NDC 0781-2613-05) and 30 ct (NDC 0781-2613-31) bottles.

Reason for Recall

Presence of Foreign Substance, Sandoz is recalling certain lots of Amoxicillin Capsules, USP 500 mg due to potential contamination with fragments of stainless steel wire mesh.

Distribution Pattern

Nationwide

Code Information

CK2003, CK2004 exp. 04/15, CR4110, CR4111, CS2983, CS2986, CS2988, CS2989, CS2990, CS2991, CS2992, CS2993, CS2994 exp. 07/15, CK3616, CK3617 exp. 04/15